Related references
Note: Only part of the references are listed.Human induced pluripotent stem cell-based platform for modeling cardiac ischemia
Martta Hakli et al.
SCIENTIFIC REPORTS (2021)
In vitro model of ischemic heart failure using human induced pluripotent stem cell-derived cardiomyocytes
Justin Davis et al.
JCI INSIGHT (2021)
Secretome Analysis Performed During in vitro Cardiac Differentiation: Discovering the Cardiac Microenvironment
Anny Waloski Robert et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Evaluation of in vitro models of stem cell-derived cardiomyocytes to screen for potential cardiotoxicity of chemicals
Miaoying Shi et al.
TOXICOLOGY IN VITRO (2020)
Reactivation of Myc transcription in the mouse heart unlocks its proliferative capacity
Megan J. Bywater et al.
NATURE COMMUNICATIONS (2020)
Cardiac natriuretic peptides
Jens P. Goetze et al.
NATURE REVIEWS CARDIOLOGY (2020)
Proteomic analysis of the cardiac myocyte secretome reveals extracellular protective functions for the ER stress response
Erik A. Blackwood et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
Cardiac hypertrophy in a dish: a human stem cell based mode
Markus Johansson et al.
BIOLOGY OPEN (2020)
Atrial and brain natriuretic peptides: Hormones secreted from the heart
Yasuaki Nakagawa et al.
PEPTIDES (2019)
Hypertrophy of human embryonic stem cell-derived cardiomyocytes supported by positive feedback between Ca2+ and diacylglycerol signals
Christine Deisl et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2019)
Mechanical stretch induced transcriptomic profiles in cardiac myocytes
Jaana Rysa et al.
SCIENTIFIC REPORTS (2018)
Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes
Ekaterina Ovchinnikova et al.
STEM CELL REPORTS (2018)
Differentiation of cardiomyocytes and generation of human engineered heart tissue
Kaja Breckwoldt et al.
NATURE PROTOCOLS (2017)
Serum Chemerin is Associated with Inflammatory and Metabolic Parameters-Results of a Population-Based Study
Stephanie Zylla et al.
OBESITY (2017)
ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage
Teruki Sato et al.
CARDIOVASCULAR RESEARCH (2017)
On the Dependency of Cellular Protein Levels on mRNA Abundance
Yansheng Liu et al.
CELL (2016)
Protein kinase C mechanisms that contribute to cardiac remodelling
Alexandra C. Newton et al.
CLINICAL SCIENCE (2016)
Chemerin Elicits Potent Constrictor Actions via Chemokine-Like Receptor 1 (CMIKLR1), not G-Protein-Coupled Receptor 1 (GPR1) in Human and Rat Vasculature
Amanda J. Kennedy et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Endothelin
Anthony P. Davenport et al.
PHARMACOLOGICAL REVIEWS (2016)
InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams
Henry Heberle et al.
BMC BIOINFORMATICS (2015)
Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart
John P. Headrick et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Serum apelin is associated with left ventricular hypertrophy in untreated hypertension patients
Lijun Ye et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Differentiation of Cardiomyocytes from Human Pluripotent Stem Cells Using Monolayer Culture
Ivan Batalov et al.
BIOMARKER INSIGHTS (2015)
Causal analysis approaches in Ingenuity Pathway Analysis
Andreas Kraemer et al.
BIOINFORMATICS (2014)
The presence of mu-, delta-, and kappa-opioid receptors in human heart tissue
Piotr Sobanski et al.
HEART AND VESSELS (2014)
Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
Erika Assarsson et al.
PLOS ONE (2014)
RNA Expression Profiling of Human iPSC-Derived Cardiomyocytes in a Cardiac Hypertrophy Model
Praful Aggarwal et al.
PLOS ONE (2014)
Antibody-based proteomics and biomarker research-Current status and limitations
Corinne Solier et al.
PROTEOMICS (2014)
Endothelin-1 Induces Myofibrillar Disarray and Contractile Vector Variability in Hypertrophic Cardiomyopathy-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Atsushi Tanaka et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth
Faye M. Drawnel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Phospholipase Cε Hydrolyzes Perinuclear Phosphatidylinositol 4-Phosphate to Regulate Cardiac Hypertrophy
Lianghui Zhang et al.
CELL (2013)
Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions
Xiaojun Lian et al.
NATURE PROTOCOLS (2013)
Glucose Regulation of Load-Induced mTOR Signaling and ER Stress in Mammalian Heart
Shiraj Sen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Phenotypic Screening with Human iPS Cell-Derived Cardiomyocytes: HTS-Compatible Assays for Interrogating Cardiac Hypertrophy
Coby Carlson et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
APJ acts as a dual receptor in cardiac hypertrophy
Maria Cecilia Scimia et al.
NATURE (2012)
Identification of hypertrophy- and heart failure-associated genes by combining in vitro and in vivo models
Bo Lu et al.
PHYSIOLOGICAL GENOMICS (2012)
Role of Endothelin in the Induction of Cardiac Hypertrophy In Vitro
Tepmanas Bupha-Intr et al.
PLOS ONE (2012)
Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling
Xiaojun Lian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Modulation of human embryonic stem cell-derived cardiomyocyte growth: A testbed for studying human cardiac hypertrophy?
Gabor Foeldes et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
Correlation between plasma levels of apelin and myocardial hypertrophy in rats and humans: possible target for treatment?
Ines Falcao-Pires et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Myocardial Apelin Production is Reduced in Humans With Left Ventricular Systolic Dysfunction
Badrinathan Chandrasekaran et al.
JOURNAL OF CARDIAC FAILURE (2010)
Identification and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytes
Miroslava Stastna et al.
PROTEOMICS (2010)
Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis
Wen Yin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Hypoxia Increases Placenta Growth Factor Expression in Human Myocardium and Cultured Neonatal Rat Cardiomyocytes
Ronald J. Torry et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2009)
Cell Cycle Re-Entry and Mitochondrial Defects in Myc-Mediated Hypertrophic Cardiomyopathy and Heart Failure
Hyoung-gon Lee et al.
PLOS ONE (2009)
1,4,5-Inositol Trisphosphate-Operated Intracellular Ca2+ Stores and Angiotensin-II/Endothelin-1 Signaling Pathway Are Functional in Human Embryonic Stem Cell-Derived Cardiomyocytes
Oshra Sedan et al.
STEM CELLS (2008)
Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II-anglotensin type 1 receptor system
Yoshitaka Iwanaga et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Hypertrophic growth in cardiac myocytes is mediated by Myc through a cyclin D2-dependent pathway
Weiguang Zhong et al.
EMBO JOURNAL (2006)
Expression profiling reveals differences in metabolic gene expression between exercise-induced cardiac effects and maladaptive cardiac hypertrophy
CC Strom et al.
FEBS JOURNAL (2005)
Hypertrophy of the heart - A new therapeutic target?
N Frey et al.
CIRCULATION (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis
GS Xiao et al.
CIRCULATION RESEARCH (2001)
Cardiomyopathy in transgenic mice with cardiacspecific overexpression of serum response factor
XM Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)
Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy
K Kunisada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)